All survival analysis data from the Kaplan−Meier plotter data set of this part manifested that WDR6 could be a potential and poor prognostic factor for gastric cancer and ovarian cancer patients, but a better prognostic biomarker for breast cancer and lung cancer patients. This evidence concerns the gene WDR6 and gastric cancer.